SOURCE: Kalorama Information

Kalorama Information

February 02, 2011 12:16 ET

Nanotechnology Revolutionizing Drug Delivery Methods: Kalorama

NEW YORK, NY--(Marketwire - February 2, 2011) - Growth in biological drugs and gene therapy is driving developments in the advanced drug delivery market. A report from healthcare market research publisher Kalorama Information, "Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)," finds that nanotechnology is the most promising area in the $60.6 billion global market for advanced drug delivery products.

Advanced drug delivery strategies are taking advantage of new entities in therapeutic pharmacology, such as proteins and peptides and other novel compounds that target drugs to specific disease sites. For Example, gene therapy has shown promise, but its development is stymied by the lack of appropriate delivery methods.

"The goal of advanced drug delivery systems is to deploy medications intact to specifically targeted parts of the body through a medium that can control the therapy's administration by means of a physiological chemical trigger," said Melissa Elder, an analyst for Kalorama Information and the author of the study. "To achieve this goal, researchers are turning to advances in micro and nanotechnology."

During the last decade, polymeric microspheres, polymer micelles, and hydrogel-type nanocarriers have all been shown to be effective in enhancing drug targeting specificity, lowering drug toxicity, improving treatment absorption rates, and providing protection for drugs against biochemical degradation.

"Some areas of nanotechnology are more advanced than others," said Elder. "However, all are playing a large role in diagnostics, pharmaceuticals and therapeutics."

Kalorama finds sales in nanomedicine are expected to spike with the highly anticipated development of monoclonal antibodies for respiratory indications, psoriasis, prevention of transplant rejection and cancer. Over twenty companies have patents in this area of development, indicating a propitious future outlook. With an increasing number of disease and cancer patients, pharmaceutical companies are facing a difficult challenge in the delivery of breakthrough medications. There is an immense revenue opportunity in nanotechnology capable of providing targeted drug delivery.

"Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)" analyzes several trends, including molecular imprinted polymers, antibiotic biodegradable implants, hot-melt extrusion technology, sorbent technology, and gene therapy drug delivery. The report concentrates on liposome and polymer drug delivery, as well as monoclonal antibodies. It is available at:

About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter ( and LinkedIn (

Contact Information